PharVision Advisers’s Peoples Bancorp PEBO Stock Holding History

PharVision Advisers’s Portfolio PEBO Stock Details PEBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,005	Closed	-$210K	–	928
2025 Q3	$210K	Buy	+7,005	New	+$212K	0.12%	477

Other funds holding PEBO

Align Financial Hermantown, Minnesota $176M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

PharVision Advisers's PEBO Position: Q4 2025 in Review

PharVision Advisers sold out of Peoples Bancorp (PEBO) in Q4 2025, closing a stake of 7,005 shares — an estimated $210K sold.

PharVision Advisers first reported a position in PEBO in Q3 2025 and held it in 1 quarter. The position peaked at $210K in Q3 2025. 212 funds tracked by Wall St. Rank hold PEBO as of Q4 2025.

PharVision Advisers reported no remaining Peoples Bancorp position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 7,005 Peoples Bancorp shares in Q4 2025, an estimated $210K.
PharVision Advisers first reported a position in Peoples Bancorp in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Peoples Bancorp position peaked at $210K in Q3 2025.
212 funds tracked by Wall St. Rank held Peoples Bancorp as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.